Story perspectives
Massachusetts Biotechs Sionna and Odyssey Prepare for IPOs
1/22/2025
50 11
1 of 1
Story summary
- Sionna Therapeutics and Odyssey Therapeutics, two innovative Massachusetts biotech firms, are set to make waves on the Nasdaq with their upcoming IPOs, $SION and $ODTX. Following the 2025 J.P. Morgan Healthcare Conference, Sionna aims to revolutionize cystic fibrosis treatments, while Odyssey is determined to tackle autoimmune diseases, using the funds to propel their clinical programs forward.
